View in EDS

Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.

Saved in:
Bibliographic Details
Title: Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.
Authors: Perez-Ruiz E; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Oncology, Hospital Costa del Sol, Marbella, Spain.; Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain., Minute L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Otano I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Alvarez M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Ochoa MC; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Belsue V; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., de Andrea C; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain., Rodriguez-Ruiz ME; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Perez-Gracia JL; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Marquez-Rodas I; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Oncology, Hospital General Universitario Gregorio Marañon, Madrid, Spain., Llacer C; Department of Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain., Alvarez M; Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain.; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain.; Department of Pathology, Faculty of Medicine, Universidad de Málaga, Málaga, Spain., de Luque V; Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain.; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain., Molina C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain., Teijeira A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain. pberraondol@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. pberraondol@unav.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. pberraondol@unav.es., Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain. imelero@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. imelero@unav.es.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain. imelero@unav.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. imelero@unav.es.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain. imelero@unav.es.
Source: Nature [Nature] 2025 Oct; Vol. 646 (8087), pp. E29-E30.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41034590
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Perez-Ruiz+E%22">Perez-Ruiz E</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Oncology, Hospital Costa del Sol, Marbella, Spain.; Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain.<br /><searchLink fieldCode="AU" term="%22Minute+L%22">Minute L</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Otano+I%22">Otano I</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Alvarez+M%22">Alvarez M</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Ochoa+MC%22">Ochoa MC</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Belsue+V%22">Belsue V</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22de+Andrea+C%22">de Andrea C</searchLink>; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Ruiz+ME%22">Rodriguez-Ruiz ME</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Perez-Gracia+JL%22">Perez-Gracia JL</searchLink>; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Marquez-Rodas+I%22">Marquez-Rodas I</searchLink>; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Oncology, Hospital General Universitario Gregorio Marañon, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Llacer+C%22">Llacer C</searchLink>; Department of Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain.<br /><searchLink fieldCode="AU" term="%22Alvarez+M%22">Alvarez M</searchLink>; Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain.; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain.; Department of Pathology, Faculty of Medicine, Universidad de Málaga, Málaga, Spain.<br /><searchLink fieldCode="AU" term="%22de+Luque+V%22">de Luque V</searchLink>; Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain.; Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain.<br /><searchLink fieldCode="AU" term="%22Molina+C%22">Molina C</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Teijeira+A%22">Teijeira A</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Berraondo+P%22">Berraondo P</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain. pberraondol@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. pberraondol@unav.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. pberraondol@unav.es.<br /><searchLink fieldCode="AU" term="%22Melero+I%22">Melero I</searchLink>; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain. imelero@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. imelero@unav.es.; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain. imelero@unav.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. imelero@unav.es.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain. imelero@unav.es.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220410462%22">Nature</searchLink> [Nature] 2025 Oct; Vol. 646 (8087), pp. E29-E30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0410462 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4687 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200280836%22">00280836 </searchLink><i>NLM ISO Abbreviation: </i>Nature <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41034590
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41586-025-09672-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: E29
    Titles:
      – TitleFull: Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Perez-Ruiz E
      – PersonEntity:
          Name:
            NameFull: Minute L
      – PersonEntity:
          Name:
            NameFull: Otano I
      – PersonEntity:
          Name:
            NameFull: Alvarez M
      – PersonEntity:
          Name:
            NameFull: Ochoa MC
      – PersonEntity:
          Name:
            NameFull: Belsue V
      – PersonEntity:
          Name:
            NameFull: de Andrea C
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Ruiz ME
      – PersonEntity:
          Name:
            NameFull: Perez-Gracia JL
      – PersonEntity:
          Name:
            NameFull: Marquez-Rodas I
      – PersonEntity:
          Name:
            NameFull: Llacer C
      – PersonEntity:
          Name:
            NameFull: Alvarez M
      – PersonEntity:
          Name:
            NameFull: de Luque V
      – PersonEntity:
          Name:
            NameFull: Molina C
      – PersonEntity:
          Name:
            NameFull: Teijeira A
      – PersonEntity:
          Name:
            NameFull: Berraondo P
      – PersonEntity:
          Name:
            NameFull: Melero I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2025 Oct
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1476-4687
          Numbering:
            – Type: volume
              Value: 646
            – Type: issue
              Value: 8087
          Titles:
            – TitleFull: Nature
              Type: main
ResultId 1